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1. INTRODUCTION 
Drugs with unsaturated side chains and certain 
dihydropyridines both convert liver haem into N- 
alkylated porphyrins, but the underlying mecha- 
nisms differ in the two cases. With unsaturated 
drugs, for example 2-allyl-2-isopropylacetamide 
(AIA), a monooxygenated erivative of the drug 
becomes bound [l] onto one of the pyrrole nitro- 
gen atoms [2-41 of liver haem; whereas with 3,5- 
diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyri- 
dine (DDC) only the 4-methyl substituent of the 
drug is transferred onto the pyrrole nitrogen atom 
[5-71 and the product, N-methyl protoporphyrin, 
is a powerful inhibitor of ferrochelatase (EC 
4.99.1.1) [8,9]. 
There is strong evidence that the N-alkylated 
porphyrins produced by unsaturated compounds 
all originate from the haem of cytochrome P-450 
[ 10-121, but it is less clear from which pool of 
hepatic haem N-methyl protoporphyrin originates 
after treatment with DDC; and the detailed mech- 
anism of the transmethylation reaction involved 
has not yet been elucidated. 
The aim of the experiments described in this pa- 
per has been to clarify wether N-methyl protopor- 
phyrin originates from the haem of cytochrome P- 
450 and whether exogenous haem can be utilized 
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for the formation of N-alkylated porphyrins. Sev- 
eral analogues of DDC have also been investigated 
to ascertain what structural characteristics the 4- 
substituent of a dihydropyridine must possess in 
order to be transferred onto the pyrrole nitrogen of 
haem. Most of this work has been carried out in 
vitro by using isolated hepatocytes, but some of the 
findings have been confiimed in the 
in vivo. 
2. MATERIALS AND METHODS 
2.1. Synthesis of dihydropyridines 
whole animal 
DDC and its 4-desmethyl and 4-ethyl analogues 
were prepared as described in [13] starting with 
acetaldehyde, formaldehyde and propionaldehyde, 
respectively. The 4-propyl, 4-isopropyl, 4-phenyl 
and 4-benzyl analogues of DDC were prepared ac- 
cording to [ 141, using n-butyraldehyde, iso-butyr- 
aldehyde, benzaldehyde and phenylacetaldehyde, 
respectively. All drugs were recrystallized from 
ethanol and had melting points in good agreement 
with those in [14,15]. Their identity was confirmed 
by NMR and infrared spectroscopy and also by 
chemical ionization mass spectrometry. 
2.2. Treatment of animals 
Fed male mice of the MFI strain were given an 
intraperitioneal injection (100 mg/kg) of either 
DDC or of its 4-isopropyl or 4-benzyl analogues 
dissolved in arachis oil (10 ml/kg) and were killed 
1 h later. Liver mitochondria and microsomes were 
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obtained [16] to estimate ferrochelatase (with 
mesoporphyrin and Cd+ [17]), and microsomal 
cytochrome P-450 [ 181 and haem [ 191, respectively. 
The N-alkylated porphyrins were extracted from 
liver homogenates and isolated by chromatogra- 
phy on Sephadex LH-20 [9]. 
Microsomes isolated from the liver of mice were 
incubated at 37°C with shaking (60 cycles/min) in 
the presence of phosphate buffer pH 7.4 (80 mM), 
EDTA (1 mM), NADPH (0.6 mM), a NADPH- 
generating system [16], and either the 4-ethyl or 
4-isopropyl analogue of DDC (0.5 mM). Cyto- 
chrome P-450 and total haem were measured be- 
fore and after incubation by dual-wavelength spec- 
trophotometry in a Perkin-Elmer, model 356 
instrument. 
2.3. Experiments with isolated hepatocytes 
Hepatocytes were prepared by a collagenase 
perfusion technique [20] from fed male rats of the 
Porton strain (some given phenobarbitone sodium, 
0.1% in drinking water for a week before use). 
They were incubated in 100 ml round-bottom 
flasks under 02/CO2 (95:5, by vol) in a modified 
Weymouth medium (40 ml, 85- 110 X 106 cells/ 
flask) in presence of glutamine (200 mM) gen- 
tamycin (50 pg/ml), NaHC03 (0.19%) heparin 
(12.5 U/ml) and heat-inactivated horse serum 
(12.5%, by vol). Incubation was at 37°C and pH 
7.4 with gentle rotation [21] (58 cycles/min, the di- 
‘rection being inverted every minute). Haematin, in 
some experiments prelabelled from 5-amino- 
[5-14C]laevulinate [22], was added as methaem- 
albumin [23]. Viability (Trypan blue exclusion) de- 
clined from 95-87% to 85-75s after incubation. 
Hepatocytes were homogenized by Ultraturrax 
(10 s at O’C) and mitochondrial ferrochelatase and 
N-alkylated porphyrins assayed as with intact 
liver, Using an &r&r = 228 for the Soret absorption 
of the dication derivative of the pigments. Cyto- 
chrome P-450 was measured as in 1241 and the in 
vitro inhibitory activity towards ferrochelatase of 
green pigments extracted from hepatocytes, as- 
sayed according to [9]. 
3. RESULTS 
3.1. Production of N-alkylated porphyrins by iso- 
lated hepatocytes 
When hepatocytes were incubated with DDC 
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Fig. 1. Decline of mitochondrial ferrochelatase and ac- 
cumulation of a N-alkylated porphyrin (or green pig- 
ment) caused by DDC (50 PM) in hepatocytes incubated 
in vitro. The accumulating pigment was strongly inhibi- 
tory on the ferrochelatase activity of normal mouse 
mitochondria. Results are means f SEM of the number 
of observations in parentheses or averages of two 
observations. 
the activity of their mitochondrial ferrochelatase 
declined (see also [25,26]), and increased amounts 
of a green pigment with inhibitory activity towards 
ferrochelatase could be isolated (fig.1). After a 30 
min incubation most of the inhibitor could already 
be demonstrated but the mitochondrial enzyme 
was still normal, probably indicating that the green 
pigment is produced outside the mitochondrion 
and has to cross the mitochondrial membranes in 
order to inhibit the enzyme. Production of a N-al- 
kylated porphyrin could also be readily demon- 
strated with AIA (see later). 
3.2. Structure of the dihydropyridines required for 
production of N-alkylated porphyrins 
A decline in hepatic cytochrome P-450 [27] and 
a loss of radioactivity from prelabelled microsomal 
haem [28] has been reported after treatment with 
DDC; whereas the oxidized analogue of DDC, 
3,5-diethoxycarbonyl-2,4,6_trimethylpyridine, which 
does not cause production of N-methyl protopor- 
phyrin [S], increases (rather than decreases) the 
concentration of cytochrome P-450 in the liver 
[29]. These findings and recent observations ob- 
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Table 1 
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Loss of cytochrome P-450 and accumulation of N-alkylated porphyrins caused in iso- 
lated hepatocytes by 3,5-diethoxycarbonyl-l,4-dihydro-2,4,6-trimethylpyridine (DDC) 
and several analogues 
Dihydropyridine analogue d 
(final cont.) 
Cytochrome P-450 
(W of corresponding 
value in sample not 
incubated) 
N-alkylated porphyrins 
(nmolllO0 X 106 cells) 
Control 89.5*4 (6) <0.17 
4-Desmethyl DDC (50 PM) 91.5 (99, 84) <0.17 
4-Desmethyl DDC (235 PM) 85.0 (91, 79) <0.17 
DDC (bMethy1, 50 PM) 77.0 (86,68) 0.7920.13 (4) 
4-Ethyl (50 IJM) 31.5*3 (4)a 1.69 f 0.22 (3)b 
4-Propyl (50 ILM) 27.0 rf: 0.8 (4)a 2.54kO.13 (3)~ 
4-isoPropy1 (50 PM) 25.0 (29,21) <0.17 
4-Phenyl (50 PM) 74.5 (79,70) <0.17 
4-Benzyl (50 PM) 50.7?2 (4)a <0.17 
a P< 0.01, when compared to corresponding control value 
b P<O.O5 
c P < 0.01, when compared to corresponding DDC value 
d The dihydropyridines used in this work differ from DDC only in the nature of the 
4-alkyl substituent (absent in the 4-desmethyl analogue) 
Rat hepatocytes were incubated for 2 h in presence of a dihydropyridine dissolved in 
ethanol (0.1 ml/40 ml of incubation mixture) or with ethanol alone (control). Results 
are means+SEM of the number of observations in parentheses or averages of two 
observations 
tained in vitro with isolated microsomes [6] sug- 
gested that cytochrome P-450 might be the source 
of N-methyl protoporphyrin. The effect of DDC 
and of several of its analogues was therefore stud- 
ied in isolated hepatocytes and an attempt made to 
relate the accumulation of N-alkylated porphyrins 
to loss of cytochrome P-450 (Table 1). 
4-Desmethyl DDC was inactive in both respects. 
On increasing the size of the 4-substituent from a 
methyl to a propyl residue, the production of N- 
alkylated porphyrins increased and there was a 
correspondingly greater loss of cytochrome. When 
however the 4-substituent was either branched 
(isopropyl) or very bulky (benzyl), considerable 
losses of cytochrome were found but accumulation 
of a N-alkylated product could not be demon- 
strated. In experiments in mice in vivo it was con- 
firmed that dihydropyridines with a 4-isopropyl or 
benzyl substituent caused greater losses of 
cytochrome P-450 (and microsomal haem) than 
DDC; but, in contrast to DDC, neither analogue 
caused accumulation of a N-alkylated porphyrin 
or inhibition of ferrochelatase (results not shown). 
When mouse liver microsomes were incubated 
with a dihydropyridine in presence of NADPH 
and oxygen, a loss of the cytochrome was found 
not only with the 4-ethyl analogue (confirming 
data in [6]), but also with the 4-isopropyl analogue; 
this was accompanied by loss of haem in both 
cases (Iig.2), indicating that the prosthetic group of 
the cytochrome was the target of the inactivation 
mechanism, whether a N-alkylated porphyrin 
could be demonstrated or not. 
The green pigments isolated after treatment with 
the 4-ethyl and 4-propyl dihydropyridines were 
identified as N-ethyl and N-propyl protopor- 
phyrin, respectively [30], confirming previous con- 
clusions [5,6] that the whole 4-alkyl substituent of a 
dihydropyridine is transferred to the pyrrole nitro- 
gen. 
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Table 2 
Effect of pretreatment of rats with phenobarbitone in vivo and of adding exogenous 
haematin in vitro on the formation of N-alkylated porphyrins caused in isolated 
hepatocytes by either AIA or the 4-ethyl dihydropyridine 
Pretreatment of 
the rat in vivo 
Exongenous Incubation N-alkylated porphyrins 
haematin time (nmol/ 100 X IO6 cells) 
Dihydropyridine AIA 
None Absent 2h 1.69kO.22 (3) 2.13 
(2.2, 2.06) 
Phenobarbitone 
Phenobarbitone 
Phenobarbitone 
Absent 
Absent 
Present 
2h 4.4 11.8 
(4.45, 4.36) (11.9, 11.7) 
4h 4.92? 0.3 1 (8) 13.14+0.8 (3) 
2h 5.79 15.97 r 1.6 (3) 
(5.55, 6.03) 
Phenobarbitone Present 4h 9.49 f 0.43 (6)” 27.4 + 2.9 (3)a 
a P<O.Ol 
b P~O.001, when compared with corresponding value obtained in absence of 
haematin 
Rat hepatocytes were incubated with AIA or 4-ethyl dihydropyridine (3,5-diethoxy- 
carbonyl-l,4-dihydro-2,6-dimethyl-4-ethylpyridine) in presence or absence of exo- 
genous haematin. The latter was added at the start of the incubation to a final con- 
centration of 6.25 PM. AIA (16 mg) and the dihydropyridine (0.6 mg) were added both 
at the beginning and after 2 h incubation, each time in 0.1 ml ethanol 
10 20 30 
Time (mins) 
3.3. Effect of pretreatment with phenobarbitone and 
of addition of haem 
Hepatocytes from phenobarbitone pretreated 
rats produced N-alkylated porphyrins on incuba- 
tion with either AIA or 4-ethyl dihydropyridine in 
significantly greater amounts than hepatocytes 
from control rats. The production of both types of 
pigments was significantly increased by exogenous 
haem, particularly after the first 2 h of incubation, 
by which time production of green pigments from 
endogenous haem was virtually complete (table 2). 
Fig.2. Effect of incubating mouse liver microsomes with 
either the 4-ethyl (o) or the 4-isopropyl (a) analogue of 
DDC (dissolved in ethanol) or with ethanol alone (0) on 
the concentration of cytochrome P-450 and total haem. 
Results are expressed as a percentage of the values of 
samples not incubated. 
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More direct evidence for conversion of exo- 
genous haem into green pigment of both classes 
was obtained by using [t‘%]haematin and demon- 
strating that the pigments, purified by TLC as the 
free carboxylic acid [9], were radioactive [30]. 
4. DISCUSSION 
This work has shown conclusively that the N-al- 
kylated porphyrins produced by treatment with 
substituted dihydropyridines originate (like the 
pigments obtained with unsaturated rugs [ 10,3 11) 
from pre-existing haem. Both endogenous liver 
haem and exogenous haem can be utilized for con- 
version to N-alkylated porphyrins. The following 
findings strongly suggest hat the endogenous pre- 
cursor pool is cytochrome P-450: (1) a correlation 
was found between loss of the cytochrome and 
production of N-alkylated porphyrins, when the 
effects of DDC, its 4-ethyl and cl-propyl analogues 
were compared; (2) the yield of N-alkylated por- 
phyrins could be increased by phenobarbitone, an 
inducer of cytochrome P-450, whereas the inhibi- 
tor SKF 525-A has been shown to decrease the 
production of N-methyl protoporphyrin after 
DDC [32]; and (3) finally, when DDC was given to 
mice at different times after labelling their liver 
haem with [5-t%]aminolaevulinate, the specific 
radioactivity of the isolated N-methyl protopor- 
phyrin declined with an apparent half-life of ap- 
prox. 7 h [30], the t% value given in [33] for the 
rapidly turning-over component of cytochrome 
P-450. 
We conclude that a dihydropyridine can transfer 
(by an oxidative mechanism leading to aromatiza- 
tion [5,6,14]) its 4-alkyl substituent o nucleophilic 
sites in the molecule of haem, among these one of 
its pyrrole nitrogens. The present results suggest 
that the process of transalkylation may be more 
efficient with 4-alkyl groups which give rise to sta- 
ble carbonium ions, in agreement with the oxida- 
tive dealkylation of dihydropyridines in chemical 
systems [ 141; however, for a N-alkylated porphyrin 
to accumulate, the 4-alkyl must possess special 
characteristics of size and shape, possibly because 
bulky carbonium ions will be sterically hindered in 
their access to the pyrrole nitrogen atom and will 
attack instead more accessible sites in the molecule 
of haem. 
In [25], analogues of DDC in which the 3- and 5- 
ethoxycarbonyl groups were replaced by cyano or 
acetyl groups were far less inhibitory towards fer- 
rochelatase than DDC itself. This finding is also 
compatible with the above mechanism of oxidative 
transfer of the 4-methyl group of DDC to a pyrrole 
nitrogen of haem (leading to N-methyl protopor- 
phyrin, the inhibitor of ferrochelatase), as it is 
known from chemical systems [14] that the oxida- 
tive elimination of the 4-alkyl group of a dihydro- 
pyridine is facilitated by the presence of bulky sub- 
stituents in the 3- and 5-positions. 
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